{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:06Z","timestamp":1789842846201,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.7759\/cureus.78960","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:37:51Z","timestamp":1739486271000},"source":"Crossref","is-referenced-by-count":2,"title":["The Compression Fracture of Thoracic Spine Due to Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Hisanori","family":"Ikuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, et al.. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016, 75:3-15. 10.1136\/annrheumdis-2015-207524","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.212","article-title":"Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity","volume":"10","author":"Radner H","year":"2014","unstructured":"Radner H, Yoshida K, Smolen JS, Solomon DH. Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity. Nat Rev Rheumatol. 2014, 10:252-256. 10.1038\/nrrheum.2013.212","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon TA","year":"2015","unstructured":"Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther. 2015, 17:212. 10.1186\/s13075-015-0728-9","journal-title":"Arthritis Res Ther"},{"key":"ref4","article-title":"Complications of immunosuppression associated with weekly low dose methotrexate","volume":"18","author":"Shiroky JB","year":"1991","unstructured":"Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol. 1991, 18:1172-1175.","journal-title":"J Rheumatol"},{"key":"ref5","article-title":"Immunodeficiency-associated lymphoproliferative disorders","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al.. Immunodeficiency-associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed.. IARC Press, Lyon; 2008."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/his.12627","article-title":"Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders","volume":"67","author":"Yamada K","year":"2015","unstructured":"Yamada K, Oshiro Y, Okamura S, et al.. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Histopathology. 2015, 67:70-80. 10.1111\/his.12627","journal-title":"Histopathology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.40017","article-title":"Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?","volume":"69","author":"Hellgren K","year":"2017","unstructured":"Hellgren K, Baecklund E, Backlin C, Sundstrom C, Smedby KE, Askling J. Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?. Arthritis Rheumatol. 2017, 69:700-708. 10.1002\/art.40017","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22306","article-title":"Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients","volume":"66","author":"Kameda T","year":"2014","unstructured":"Kameda T, Dobashi H, Miyatake N, et al.. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2014, 66:1302-1309. 10.1002\/acr.22306","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref9","article-title":"Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms","volume":"53","author":"Kurzrock R","year":"1993","unstructured":"Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res. 1993, 53:2118-2122.","journal-title":"Cancer Res"},{"key":"ref10","article-title":"Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate","volume":"18","author":"Ellman MH","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991, 18:1741-1743.","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-021-03764-1","article-title":"Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report","volume":"50","author":"Kamio S","year":"2021","unstructured":"Kamio S, Anazawa U, Watanabe I, Sasaki A, Aoyama R. Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report. Skeletal Radiol. 2021, 50:2117-2123. 10.1007\/s00256-021-03764-1","journal-title":"Skeletal Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13415","article-title":"Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: a case report","volume":"46","author":"Hirata C","year":"2021","unstructured":"Hirata C, Kenzaka T, Akita H. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: a case report. J Clin Pharm Ther. 2021, 46:1178-1181. 10.1111\/jcpt.13415","journal-title":"J Clin Pharm Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27692","article-title":"Methotrexate-associated lymphoproliferative disease of the thoracic spine misdiagnosed as metastatic spinal tumor: a case report","volume":"14","author":"Tsukamoto M","year":"2022","unstructured":"Tsukamoto M, Morimoto T, Hirata H, Yoshihara T, Mawatari M. Methotrexate-associated lymphoproliferative disease of the thoracic spine misdiagnosed as metastatic spinal tumor: a case report. Cureus. 2022, 14:e27692. 10.7759\/cureus.27692","journal-title":"Cureus"},{"key":"ref14","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al.. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007, 34:322-331.","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1352477","article-title":"Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective","volume":"28","author":"Harigai M","year":"2018","unstructured":"Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective. Mod Rheumatol. 2018, 28:1-8. 10.1080\/14397595.2017.1352477","journal-title":"Mod Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al.. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013, 91:20-28. 10.1111\/ejh.12116","journal-title":"Eur J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022769","article-title":"Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal","volume":"56","author":"Inui Y","year":"2015","unstructured":"Inui Y, Matsuoka H, Yakushijin K, et al.. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma. 2015, 56:3045-3051. 10.3109\/10428194.2015.1022769","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01517.x","article-title":"Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate","volume":"101","author":"Niitsu N","year":"2010","unstructured":"Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci. 2010, 101:1309-1313. 10.1111\/j.1349-7006.2010.01517.x","journal-title":"Cancer Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette X","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002, 99:3909-3915. 10.1182\/blood.v99.11.3909","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/bjrcr\/uaae002","article-title":"The first case of methotrexate-associated lymphoproliferative disorder in the sacrum: a case report","volume":"10","author":"Yamaguchi Y","year":"2024","unstructured":"Yamaguchi Y, Morimoto T, Toda Y, et al.. The first case of methotrexate-associated lymphoproliferative disorder in the sacrum: a case report. BJR Case Rep. 2024, 10:uaae002. 10.1093\/bjrcr\/uaae002","journal-title":"BJR Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22783","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh JA","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, et al.. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016, 68:1-25. 10.1002\/acr.22783","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2018.1675","article-title":"Lymphoproliferative disorder in an elderly rheumatoid arthritis patient after longterm oral methotrexate administration: a case report","volume":"9","author":"Hashimoto K","year":"2018","unstructured":"Hashimoto K, Akagi M. Lymphoproliferative disorder in an elderly rheumatoid arthritis patient after longterm oral methotrexate administration: a case report. Mol Clin Oncol. 2018, 9:293-296. 10.3892\/mco.2018.1675","journal-title":"Mol Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337079-the-compression-fracture-of-thoracic-spine-due-to-methotrexate-associated-lymphoproliferative-disorder-in-rheumatoid-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:37:53Z","timestamp":1739486273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337079-the-compression-fracture-of-thoracic-spine-due-to-methotrexate-associated-lymphoproliferative-disorder-in-rheumatoid-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.78960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}